 acebutolol effect lipid profil erratum Am cardiol dec relat lipid profil incid coronari arteri diseas result epidemiolog intervent studi antihypertens agent beta blocker intrins sympathomimet activ isa neg effect lipid risk coronari arteri diseas ongo treatment mild hypertens studi third year patient date regard profil addit end point multicent double-blind studi blood pressur reduct target organ deterior trial patient nutrit behavior counsel diet exercis habit alcohol sodium consumpt hypertens nonpharmacolog mean addit patient low dose class antihypertens medic acebutolol beta blocker isa amlodipin calcium channel blocker chlorthalidon diuret doxazosin alpha blocker angiotensin-convert enzym inhibitor placebo year acebutolol signific decreas total cholesterol mg/dl placebo mg/dl chlorthalidon mg/dl signific decreas low-dens lipoprotein cholesterol mg/dl placebo mg/dl chlorthalidon mg/dl chang high-dens lipoprotein cholesterol mg/dl